LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Triple-negative breast cancer (TNBC) is a highly metastatic breast cancer subtype and due to the lack of hormone receptors and HER2 expression, TNBC has limited therapeutic options with chemotherapy being the primary choice for systemic therapy. LIM Domain Kinase 2 (LIMK2) is a serine/threonine kinase that plays an important role in the regulation...
Alternative Titles
Full title
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7455732
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7455732
Other Identifiers
ISSN
2157-9024
E-ISSN
2157-9024
DOI
10.1038/s41389-020-00263-1
